IQVIA Holdings Inc a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, announced it has entered into an agreement to acquire certain discovery services assets from Charles River Laboratories.
India and Brazil formalised a partnership to deepen cooperation in the regulation of pharmaceutical and medical products by signing a Memorandum of Understanding (MoU) between India’s Central Drugs Standard Control Organisation (CDSCO) and the Brazilian Health Regulatory Agency (ANVISA).
In a major step to strengthen the country’s immunization framework, Union Health Minister JP Nadda inaugurated the indigenously manufactured Tetanus and Adult Diphtheria (Td) vaccine at the Central Research Institute (CRI), Kasauli
With the patent expiry of semaglutide in India scheduled for March 2026, several leading Indian pharmaceutical companies are preparing to launch generic versions of the widely used diabetes and weight-loss drug.
Novartis today announced plans to establish a new 46,000-square-foot radioligand therapy (RLT) manufacturing facility in Denton, Texas, as part of its broader strategy to expand advanced cancer treatment capabilities across the United States.
The ECHS Central Organisation is located at Delhi and functions under the Chief of Staff Committee (COSC) through AG and DGDC&W in Army HQ. The Central organisation is headed by Managing Director, ECHS, a serving Major General. There are 28 Regional Centres ECHS and 426 ECHS Polyclinics. ECHS is also an attached office of Dept of Ex-Servivemen Welfare (DoESW), Ministry of Defence (MoD) as are Directorate General Resettlement(DGR) and Kendriya Sainik Board (KSB).
Registered Pharmacist of a recognized institution. Pay Rs. 40,800/- for three years, thereafter, after considering the performance evaluation, Level-5 Pay Matrix Rs. Basic + other allowances as per rules in the grade of 29200/92300